OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENT: OCTINOXATE 2.5%
ACTIVE INGREDIENT: OCTINOXATE 2.5%
WARNING: KEEP OUT OF EYES. STOP USE IF IRRITATION OCCURS. KEEP OUT OF REACH OF CHILDREN.
PRINCIPAL DISPLAY PANEL:
MAC
MINERALIZE
SPF 15 FOUNDATION
NET WT./POIDS NET 10g/0.35 US OZ
DIST. BY MAKE-UP ART COSMETICS
TORONTO, ONTARIO, CANADA M5V 1R7
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 40046-0037-1 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d1e5-621f-e053-dbdaa90a74ad | 922394f8-e3c7-405f-905c-4195145c46aa |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 40046-0037-1 | MINERALIZE FOUNDATIONSPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 40046-0037-2 | MINERALIZE FOUNDATIONSPF 15 | 10 g in 1 JAR | CREAM | 10 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 40046-0037 | MINERALIZE FOUNDATION SPF 15 (OCTINOXATE) CREAM [MAKE-UP ART COSMETICS] | 1 | Legacy NDC, 2 package rows | 20100728_922394f8-e3c7-405f-905c-4195145c46aa.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 40046-0037 | 40046-0037-2, 40046-0037-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| db752197-9555-43ce-adc3-7fb0b7194f2c | 922394f8-e3c7-405f-905c-4195145c46aa | 2010-05-18 | Warnings | db752197-9555-43ce-adc3-7fb0b7194f2c 922394f8-e3c7-405f-905c-4195145c46aa |
Adverse event summaries are temporarily unavailable. Other product information remains available.